Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies

September 30, 2025 8:00 AM

Wellgistics Health, Inc. ("Wellgistics Health" or the "Company") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced a strategic collaboration with TheracosBio, the manufacturer of Brenzavvy® (bexagliflozin), to make diabetes medications more affordable and accessible across the U.S. healthcare system.The joint effort leverages Wellgistics Health's...

Read more

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

September 30, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its aesthetic business, Solta Medical, a global leader in the medical aesthetics market, will be featured on The Balancing Act, airing on Lifetime, in a special episode spotlighting its portfolio of non-invasive skin rejuvenation and tightening technologies: Thermage® FLX, Clear + Brilliant® and Fraxel FTX™. Hosted by Montel Williams and Olga...

Read more

MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction

September 30, 2025 7:30 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced that it has completed its acquisition of SKNY Pharmaceuticals, Inc. ("SKNY").As part of the transaction, SKNY fulfilled all closing obligations, contributing $5 million in marketable securities to MIRA, further strengthening...

Read more

Bausch Health to Announce Third Quarter 2025 Results on October 29

September 30, 2025 7:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call...

Read more

CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars

September 30, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), through its operating subsidiary CBD Vault, today announced a game-changing client acquisition with Smoking Scholars, a premier dispensary located at 784 Allerton Ave in the Bronx, New York. This strategic agreement, finalized following CBDL's successful showcase at the NECANN New Jersey Conference, positions the Company to capture a powerful share of the booming New York cannabis and CBD marketplace.Smoking...

Read more

Long-Standing Partners in Science: Bioz and JULABO USA Drive Faster, Smarter Discovery

September 30, 2025 4:00 AM

Bioz, Inc., the pioneer in evidence-based product validation, is proud to announce the expansion of its partnership with JULABO USA, a subsidiary of the global leader in temperature control innovation. For over five decades, JULABO has defined excellence in precision heating and cooling systems, enabling scientists, engineers, and manufacturers to perform critical experiments and processes with unmatched consistency.As part of its ongoing...

Read more

Genflow Biosciences PLC Announces Half-Year Report

September 30, 2025 2:00 AM

Genflow (LSE:GENF)(OTCQB:GENFF) is pleased to announce its half year results for the six-month period ended 30 June 2025.Chairman's StatementIt is my pleasure to update shareholders of Genflow Biosciences Plc ("Genflow" or the "Company") on our performance during the first six months of 2025.As of 30 June 2025, Genflow has made important progress across its programs in both human health and animal health, advancing our mission to extend...

Read more

Hemogenyx Pharmaceuticals PLC Announces Half-year Report

September 30, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, whose Shares are admitted to the equity shares (transition) category of the Official List, announces its unaudited interim results for the six-month period ended 30 June 2025. All financial amounts are stated in GBP British pounds unless otherwise indicated.Key HighlightsFirst-in-human treatment with HG-CT-1...

Read more

Change in Number of Shares and Votes in Ascelia Pharma AB

September 30, 2025 1:45 AM

During September, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma")(STO:ACE) has increased due to conversion of outstanding convertibles issued by Ascelia Pharma to Fenja Capital II A/S on 13 September 2024 and due to the directed new issue of ordinary shares which was announced by Ascelia Pharma on 22 September 2025. As of 30 September 2025, the total number of shares in Ascelia Pharma amounts to 127,902,580...

Read more

AUA Guidelines Recognize NGS in Recurrent UTI Care, Signaling Progress

September 29, 2025 5:00 PM

The American Urological Association (AUA) has amended its 2025 recurring urinary tract infection treatment guidelines to recognize Next-Generation Sequencing (NGS) as a diagnostic aid.This update reflects the growing body of evidence that NGS is a compelling option for urinary diagnostics. It highlights the limits of urine culture, long considered the gold standard, as it can lack the speed and breadth to inform optimal patient care.NGS detects...

Read more

Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes

September 29, 2025 12:35 PM

Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan to conduct an Institutional Review Board (IRB) study that could fundamentally transform the cannabinoid edible and nutraceutical markets.The study is designed to demonstrate the dramatically enhanced efficacy of CBD-loaded exosomes in oral delivery. This research is predicated on the known ability of our...

Read more

Teva’s Journey to 100% Renewable Electricity: Bold Targets, Bold Solutions

September 29, 2025 11:25 AM

Reaching 100% renewable electricity in 10 years - that's a bold target. And bold targets require bold solutions.One way Teva is working toward this target is through Virtual Power Purchase Agreements, or VPPAs. These are long-term contracts that help build new clean energy projects, like solar farms. They go beyond Teva sites and bring more renewable energy into the public grid.Teva just signed its second VPPA for a new solar project in...

Read more

Dr. Scott H. Froum Named Best Periodontal Office in New York City for Second Consecutive Year

September 29, 2025 11:20 AM

Dr. Scott H. Froum, a board-certified periodontist and recognized leader in dental implants, gum disease treatment, and tooth-saving procedures, has once again been honored as the Best Periodontal Office in New York City for the second consecutive year in the highly competitive The City's Best contest.This annual contest, organized by Schneps Media, celebrates excellence across multiple industries in New York City. Winners are selected...

Read more

Fortified Health Security Acquires Latitude, Expands Cybersecurity Advisory Capabilities

September 29, 2025 11:00 AM

Fortified Health Security (Fortified), a Best in KLAS managed security services provider (MSSP) specializing in healthcare cybersecurity, today announced its acquisition of Latitude Information Security (Latitude), a healthcare-focused cybersecurity advisory firm known for its expertise in HITRUST CSF, risk assessments and third-party risk management.This strategic move scaled Fortified's ability to deliver healthcare advisory and HITRUST...

Read more

Miracle CEO Defeats Cancer and Leads Medical AI Innovation at (OTC PINK:MDCE) Medical Care Technologies Inc.

September 29, 2025 10:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announces a new era of leadership and innovation under CEO Marshall Perkins, whose extraordinary personal journey is now fueling the company's mission to transform healthcare. In early 2025, Perkins faced a near-fatal battle with advanced bone cancer that destroyed multiple vertebrae and left him hospitalized for months. At the same time, he confronted vitiligo, a challenging skin condition....

Read more

dHealth Intelligence Launches Revolutionary AI Agent That Transforms Personal Healthcare Management

September 29, 2025 9:50 AM

Healthcare AI startup dHealth Intelligence just unveiled an AI agent that consolidates fragmented medical data & provides advice based on it, while protecting patient privacy. Available now as a free desktop download, the platform transforms scattered medical records, fitness data, and doctor's notes into a unified health narrative through simple user commands. It also provides fully private AI medical consultations. Mobile versions arrive Q1...

Read more

P-n-T Data Corp. Announces Full Board of Directors and Executive Leadership Team

September 29, 2025 9:00 AM

P-n-T Data Corp., a provider of managed services for healthcare data sharing, today formally announced its full Board of Directors and executive leadership team. Together, these individuals bring deep domain expertise in healthcare, cybersecurity, finance, enterprise systems, and artificial intelligence - critical pillars supporting the company's Post-n-Track Gen 3 platform and mission to de-risk healthcare data sharing and residency.The Board...

Read more

The Keloid Plastic Surgery Center Discusses How to Treat Ear Keloids From Piercings and Trauma

September 29, 2025 8:00 AM

Ear keloids are a challenging type of scar that can develop after piercings, injuries, or other forms of trauma to the ear. These scars not only change the appearance of the ear but can also cause discomfort, tenderness, or itchiness. For patients who struggle with ear keloids, effective treatment can feel difficult to find. The Keloid Plastic Surgery Center, with offices in Miami Beach and Aventura, provides specialized options designed to...

Read more

Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

September 29, 2025 8:00 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market, today announced the exercise of certain existing warrants issued in May 2023 and March 2025 (the "Existing Warrants") at a reduced exercise price of $0.68 per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered...

Read more

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

September 29, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its dentistry business, OraPharma, today announced the launch of OraTalks, a new podcast created to ignite meaningful dialogue and explore the challenges shaping modern dentistry.Season One of OraTalks features nine episodes covering timely topics in oral health and patient care, such as sleep disorders, women's health, social determinants, and...

Read more